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Objectives: To examine the frequency of pharmaceutical company representative (PCR) interactions with
doctors in Libya and review possible associations between these interactions and the personal and practice
setting characteristics of doctors.
Method: An anonymous survey questionnaire was circulated to 1,000 Libyan doctors in selected public and
private practice settings in Tripoli, Benghazi and Sebha.
Results: A questionnaire return rate of 61% (608 returned questionnaires) was achieved. Most respondents
(94%) reported that they had been visited by PCRs at least ‘once’ in the last year. Fifty per cent of respondents
met with PCRs at least once a month, and 20% at least once a week. The following characteristics were
significantly associated with meeting with a representative more than once a week: age, gender (male female),
years of practice, being a specialist (other than an anaesthesiologist) or working in private practice. Ninety-one
per cent of doctors reported that they had received at least one kind of relationship gift during the last year.
Printed materials (79%), simple gifts (73%) and drug samples (69%) were the most common relationship
products given to respondents. Reimbursements or sponsored items were reported by 33% of respondents.
Physician specialists were more likely to receive drug samples or sponsored items than residents, general
practitioners, anaesthesiologists or surgeons (PB0.01). Participants working in private practice alone or in
both sectors were more likely to receive printed materials, simple gifts or free samples from PCRs than doctors
working in the public sector (PB0.05).
Conclusion: Libyan doctors are frequently visited by PCRs. Doctors, working in private practice or specialist
practice, are especially targeted by promotional activities. An agreed code of conduct for pharmaceutical
promotion in Libya between doctors and PCRs should be created.
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E
xpenditure on pharmaceuticals is a substantial
component of the health care budgets of most
nations. In 2009, the expenditure on prescrip-
tion drugs in the United States was approximately $300
billion (1).
Marketing and promotional activities constitute a large
proportion of the budgets of pharmaceutical companies,
and approximately 30% of the employees in pharmaceu-
tical companies are engaged in marketing activities (2).
In the United States, companies spend more than $11
billion annually on pharmaceutical promotion, and in
2004 alone they spent $7 billion on direct marketing to
clinicians (3).
Amongst the marketing techniques employed by the
pharmaceutical industry, the use of pharmaceutical com-
pany representatives (PCRs) constitutes one of the most
expensive and extensively used promotional tools (2, 4, 5).
A PCR can be defined as a drug company employee who
regularly visits physicians to provide information on the
company’s products. A successful PCR has a high sales
rate, dominates his or her business region and has an
ability to maintain clients (6). It has been estimated that
pharmaceutical companies spend approximately $8,000
13,000 per doctor per year (7), and of the $11 billion spent
annually on promotion, 45% is allocated to PCR activities
(8, 9).
Contact between a PCR and a medical practitioner is
therefore viewed by drug companies as a vital part of
their marketing strategy. Evidence suggests that in most
countries 8090% of doctors are frequently visited by
PCRs (10). Wazana reviewed 16 studies from the inter-
national literature and reported that the majority of
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medical practitioners usually meet with PCRs approxi-
mately four times a month (11).
To establish or maintain their relationship with pre-
scribers, PCRs employ many techniques. Gift-giving is
a common practice in many cultures and industries.
Pharmaceutical companies spend between $12 and 15
billion a year on gifts and payments (12, 13). PCRs often
offer doctors a variety of simple gifts during visits such
as stationery supplies bearing company product trade
names during their visits. Moderately priced gifts ($20
100), such as textbooks or meal invitations, are also
common inducements offered by PCRs. ‘Noteworthy’ or
expensive gifts such as travel for attendance of conferences
or invitations as speakers in pharmaceutical-sponsored
activities are sometimes provided (14). Distributing ‘free’
drug samples to physicians is also a commonly employed
practice. In 2004 alone, the Kaiser Family Foundation
reported that pharmaceutical companies spent $15.9
billion marketing drug samples to physicians and that
this represented the largest component of their promo-
tional budget (57%) (3).
Visits and gifts from PCRs are designed to increase
prescription sales for specific products (15) and can
cultivate subconscious commercial or conflict of interest
relationships with prescribers (13). From an industry
perspective companies assert that the interactions be-
tween their PCRs and medical practitioners result in
raised awareness of their products and therefore have
direct benefits for patients (16). The difficulty with gift
giving, however, centres around the perception that
accepting gifts can imply a social relationship and this
obligation relationship may generate a potential conflict
of interest (17). Studies have reported that pharmaceu-
tical promotional interactions with doctors can have a
negative impact on prescribing practice (11).
The majority of pharmaceutical marketing occurs in
developed countries, and in 2006 as a proportion of the
international market for pharmaceuticals, the Middle-
East and North Africa regions contributed only 1.8%
(18). In Libya, pharmaceutical supplies were previously
provided to both the public and private sectors by the
National Pharmaceutical and Medical Supplies Com-
pany, but currently international pharmaceutical com-
panies are also permitted to market and supply their
products through both public and private health sectors
via local agencies (19). In 2009, over 300 multinational
pharmaceutical manufacturers from Europe, Asia and
the Middle East were registered as permitted drug sup-
pliers to Libya (20). Pharmaceutical promotion guide-
lines exist in many developed countries to prevent or
discourage potentially unethical practices (2125), but
most developing countries do not have official policies
or codes of conduct to regulate the conduct or content
of visits.
It has been demonstrated that doctors’ personal, demo-
graphic and professional practice settings can influence
their involvement in promotional activities (11, 2630).
Since there has been little or no research to investigate
the extent and determinants of doctors’ participation
with the marketing and promotional activities used by
PCRs in Libya, the aim of this study was to examine
the extent of doctors’ involvements in PCRs’ activities
and determine whether demographic or practice char-
acteristics were associated with engagement in these
activities.
Method
An anonymous survey was conducted to investigate
Libyan doctors’ interactions with PCRs. As the central
database of practicing doctors in Libya was not acces-
sible, it was decided to use a convenience sample to target
medical practitioners of the major hospitals of Tripoli,
Benghazi and Sebha, the three main Libyan cities that
represent a diversity of geographical areas and popula-
tion size. Hospitals approached included public, private
and university hospitals. Medical practitioners from each
city’s major public and private hospitals and health
services (see Appendix) were invited to participate in
the study. All types of primary and secondary care
providers were targeted; however, some specialties were
excluded because doctors in these specialties (radiolo-
gists, pathologists, medical geneticists and preventive
medicine physicians) typically prescribe few medications
to patients and would therefore potentially be targeted
less by PCRs.
A self-administered questionnaire was developed based
on previous published studies (28, 29, 3133) to examine
the characteristics of the respondents and their practices,
the frequency of promotional visits and the range of
pharmaceutical promotional activities experienced. For
the purposes of this study, printed materials were defined
as any journal, brochure or pamphlet. A simple gift was
defined as any stationery item (such as a pen, notepad,
diary or calendar). A sponsored item was defined as
travel, luggage and assistance with conference attendance
or provision of meals. An inducement referred to direct
payment or reward for prescribing the promoted drug.
The questions assessed in this publication were as
detailed in Fig. 1.
Survey administration
A letter from the Libyan embassy in Australia endorsing
the researcher was provided to the administration depart-
ments of the major hospitals in Tripoli, Benghazi and
Sebha. The chief researcher then asked permission from
each institute to distribute the questionnaires. He was
granted access to each of the institutions listed in the
Appendix and personally invited participation.
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4.    How often were you given any of the following promotional tools over the last 12
       months? 
Printed materials (journal articles,
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Fig. 1. Questions employed to examine visiting frequency, personal characteristics, practice characteristics, visiting frequency
and receipt of promotional tools.
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Doctors were invited to voluntarily participate in the
anonymous survey, and each survey form was accom-
panied by a cover letter, supplied with a sealed envelope
that contained the questionnaire. The objectives of the
study were also personally explained to all participants as
well as explanations regarding the techniques employed
to assure confidentiality and anonymity. If agreeable to
participation, the doctors were provided with the ques-
tionnaire to complete at a convenient time. As detailed
previously, the questionnaire was provided to the doctors
in a sealed envelope (with no personally identifiable labels
on the survey form) to ensure the confidentiality and
anonymity of the survey. After completion, the survey
was handed to the hospital medical secretary in a
separate sealed anonymous envelope for collection by
the chief researcher at a later date. If a doctor was not
able to fill out the questionnaires because of a heavy
workload or were not available, they were visited a second
and third time to encourage participation. All the col-
lected sealed questionnaires were not opened until the
entire data collection period was completed. The study
was conducted between August and October 2010.
The original target sample involved issuing 1,000
questionnaires with a return expectation of more than
50%. The study was approved by the University of South
Australia’s Human Research Ethics Committee.
Statistical analysis
The data from the survey was entered into Microsoft
Excel 2007. All analyses were then performed with
the Statistical Package for the Social Sciences (SPSS
version 17), and reported P values were all two-tailed.
Bivariate analyses were carried out to examine possible
associations between subject’s or practice characteristics
and each of the promotional tools. We performed pairwise
comparisons between subgroups for each independent
variable.
Non-parametric statistical techniques (KruskalWallis
Test, MannWhitney test and Gamma test) were em-
ployed to further examine the significance of the data.
Logistic regression was also used to assess possible
associations between personal and practice characteri-
stics of respondents (age, gender, years of practice, prac-
tice setting, location of practice setting and area of
practice) and visiting rates and frequency of receiving
promotional tools. For the regression analysis of fre-
quency of receiving any promotional tool versus visiting
rate, the population was divided into those practitioners
who were visited at least once a week versus those doctors
who were visited less than once a week. To further assess
factors that might influence the receipt of particular
promotional tools, the population was divided into those
practitioners who never received the promotional tool
versus those who did.
Both unadjusted and adjusted odds ratio models
were used for logistic regression analysis. The unadjusted
effects model examined relationships between each in-
dividual predictor variable and the dependent variable
without controlling for the other variables in the model,
while the adjusted effects analysis examined the impact of
a given variable after controlling for the other predictor
variables.
Results
General characteristics of the sample
Of the 1,000 questionnaires circulated, 616 questionnaires
were returned. Eight questionnaires had incomplete data
and were omitted from the final analysis. Six hundred and
eight (61%) of the returned questionnaires were therefore
included for analysis.
There were more male respondents (371; 61%) than
female respondents (237; 39%), with the majority from
Tripoli (481; 79%). Of respondents, 399 (66%) were in
the younger age group [2535]. This was also reflected
in the number of years of practice analysis where the
largest group of respondents had between 1 and 3 years
of practice experience (288; 47%). The majority (274;
45%) of respondents were general practitioners and were
employed in the public sector (512; 84%) (Table 1).
Visiting rate
Most doctors (574; 94%) reported that they had been
visited by PCRs at least ‘once’ in the last year (Table 1).
Of the 574 doctors, 286 (50%) reported at least one visit
a month. Approximately one-fifth of respondents (118;
20.5%) reported that they had been visited at least ‘once
a week’, while 14 (2.6%) doctors reported one or more
interaction with a PCR each day (Table 1).
Gender
Female doctors were visited less frequently by PCRs
(PB0.001) (Table 1). The majority of female respondents
(62%) were visited at least once every 3 months compared
to at least once a month for the majority of male doctors
(52%). Out of 88 respondents who reported they had
interactions with PCRs at least ‘once a week’, only 33
(25%) were female. Male doctors were more than twice as
likely as female doctors to see PCRs at least once a week
(unadjusted OR2.14; PB0.01) (Table 2).
Age
There was a statistically significant difference in visit-
ing rates based on age group (PB0.001) (Table 1). All
doctors older than age 45 communicated with PCRs.
Of the 162 (27%) respondents who only reported
interacting with PCRs ‘once to twice a year’, 125 (77%)
were in the 25 to 35-year age group. By contrast,
respondents in the 5665 age group were more than three
Mustafa A. Alssageer and Stefan R. Kowalski
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Table 1. Likelihood of meeting with a PCR vs. specific characteristics of the doctor


















Age, PB0.001 (Gamma test)
2535 32 (8) 125 (31) 81 (20) 62 (16) 40 (10) 27 (7) 25 (6) 7 (2) 399 (66)
3645V 3 (2) 22 (18) 27 (22) 20 (16) 21 (17) 8 (7) 18 (15) 4 (3) 123 (20)
4655V 0 10 (16) 17 (27) 8 (13) 8 (13) 4 (6) 15 (23) 2 (3) 64 (11)
5665V 0 5 (23) 2 (9) 1 (5) 6 (27) 2 (9) 5 (23) 1 (5) 22 (3)
Gender
Female 20 (8) 74 (31) 56 (24) 35 (15) 22 (9) 14 (6) 14 (6) 2 (1) 237 (61)
MaleV 15 (4) 88 (24) 71 (19) 56 (15) 53 (14) 27 (7) 49 (13) 12 (3) 371 (39)
Years of practice, PB0.001 (Gamma test)
13 30 (10) 102 (35) 55 (19) 41 (14) 25 (9) 14 (5) 16 (6) 5 (2) 288 (47)
46V 2 (2) 16 (20) 24 (29) 14 (17) 11 (13) 10 (12) 3 (4) 2 (2) 82 (14)
79V 2 (2) 13 (29) 7 (16) 5 (11) 7 (16) 5 (11) 6 (13) 0 (0) 45 (8)
]10V 1 (0.5) 31 (16) 41 (21) 31 (16) 32 (17) 12 (6) 38 (20) 7 (4) 193 (32)
Practice setting, PB0.001 (Kruskal-Wallis)
Public 35 (7) 150 (29) 119 (23) 80 (16) 55 (11) 26 (5) 40 (8) 7 (1) 512 (84)
PrivateV 0 (0) 2 (6) 2 (6) 1 (3) 6 (18) 9 (26) 12 (35) 2 (6) 34 (6)
BothV 0 (0) 10 (16) 6 (10) 10 (16) 14 (23) 6 (10) 11 (18) 5 (8) 62 (10)
Location of practice setting, P0.002 (Kruskal-Wallis)
Sebha 3 (6) 25 (50) 8 (16) 4 (8) 3 (6) 3 (6) 3 (6) 1 (2) 50 (79)
Benghazi 8 (10) 20 (26) 17 (22) 14 (18) 8 (10) 1 (1) 6 (8) 3 (4) 77 (13)
TripoliV 24 (5) 117 (24) 102 (21) 73 (15) 64 (13) 37 (8) 54 (11) 10 (2) 481 (8)
Area of practice, PB0.001 (Kruskal-Wallis)
Resident medical officer 15 (37) 13 (32) 6 (15) 4 (10) 2 (5) 1 (2) 0 0 41 (7)
AnaesthesiologistV,# 2 (3) 32 (52) 12 (20) 8 (13) 3 (5) 1 (2) 2 (3) 1 (2) 61 (10)
GPV 14 (5) 75 (27) 61 (22) 47 (17) 30 (11) 20 (7) 23 (8) 4 (1) 274 (45)
SurgeonV 3 (3) 27 (27) 24 (24) 13 (13) 13 (13) 8 (8) 9 (9) 2 (2) 99 (16)
OthersV,# 0 (0) 5 (12) 10 (24) 8 (19) 8 (19) 5 (12) 5 (12) 1 (2) 42 (7)
Physician specialistV,# 1 (1) 10 (11) 14 (15) 11 (12) 19 (21) 6 (7) 24 (26) 6 (7) 91 (15)
Total 35 162 127 91 75 41 63 14 608
VMann Whitney test significant for comparison with the first category in the group.















































































































times as likely as those aged 2535 to be visited by
PCRs at least ‘once each week’ (unadjusted OR3.29;
PB0.05) (Table 2).
Years of practice
Doctors who had been practicing for in excess of 10 years
were more than three times as likely as those having ‘13
years of practice’ to meet a PCR at least once a week
(unadjusted OR3.03; PB0.001) (Table 2).
The majority (63%) of senior doctors (]10 years of
practice) saw PCRs at least once a month (Table 1). Of
the 14 respondents who saw PCRs ‘once a day’, 50% had
at least 10 years of practice. The more than 10 years of
practice group also reported high results for the two visits
a week (60%) or once a week response (30%). Only 1%
of respondents from this group reported that they had
not interacted with PCRs in the previous 12 months.
By contrast, the majority of junior doctors (64%) were
visited less than once every 3 months. Only 35 (13%)
doctors with 13 years of practice experience were visited
by PCRs more than once a week, and 10% of respondents
from this age group also reported that they had never
interacted with a PCR.
Practice setting
All participants who worked in the private sector either
exclusively or in both private and public sectors reported
that they had been visited by PCRs at least once during
the last 12 months. The majority of respondents (67%)
who worked in the private sector interacted with PCRs
Table 2. Likelihood of meeting with a PCR more than once a week vs. specific characteristics of the doctor
Unadjusted Adjusted
B1/week N (%) ]1/week N (%) Sig OR 95% CI Sig OR 95% CI
Age*
2535 340 (85) 59 (15) 1 1
3645 93 (76) 30 (24) 0.014 1.85 1.13.0 0.600 0.76 0.22.08
4655 43 (67) 21 (34) 0.001 2.81 1.55.0 0.740 0.818 0.22.6
5665V 14 (64) 8 (36) 0.010 3.29 1.38.2 0.926 1.069 0.24.4
Gender*
Female 207 (87) 30 (13) 1
Male 283 (76) 88 (24) 0.001 2.14 1.33.3 0.071 1.615 0.92.7
Years of practice*
13 253 (88) 35 (12) 1 1
46 67 (82) 15 (18) 0.154 1.61 0.833.13 0.690 1.157 0.52.3
79 34 (76) 11 (24) 0.030 2.33 1.085.0 0.150 1.929 0.74.7
]10 136 (70) 57 (30) B0.001 3.03 1.84.8 0.432 1.568 0.54.8
Practice setting*,**
Public 439 (86) 73 (14) 1 1
Private 11 (32) 23 (68) B0.001** 12.5 5.826.8 B0.001 11.175 4.825.7
Both 40 (65) 22 (35) B0.001** 3.30 1.855.8 0.003 2.644 1.44.9
Location of practice setting
Sebha 43 (86) 7 ( 14) 1 1
Benghazi 67 (87) 10 (13) 0.870 0.917 0.322.5 0.490 1.370 0.53.3
Tripoli 288 (79) 101 (21) 0.246 1.63 0.713.7 0.618 0.749 0.22.3
Area of practice*,**
Resident medical officer 40 (98) 1 (2) 1 1
Anaesthesiologists 57 (93) 4 (7) 0.364 2.8 0.3026 0.767 1.414 0.113.9
GP 227 (83) 47 (17) 0.039 8.2 1.161.7 0.087 5.861 0.744.4
Surgeons 80 (81) 19 (19) 0.031 9.5 1.273.5 0.216 3.832 0.431.5
Others 31 (74) 11 (26) 0.013 14.1 1.7115 0.083 6.832 0.759.9
Physician specialists 55 (60) 36 (40) 0.002** 26.1 3.4199 0.025 11.544 1.398.5
*Unadjusted OR significant PB0.05
**Adjusted OR significant PB0.05.
CI: Confidence interval.
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at least once a week (Table 1). There was a statistically
significant difference in visiting rates according to their
practice setting (PB0.001).
Twenty-three (67%) participants who worked in the
private sector were visited at least once a week compared
with 73 (14%) from the public sector. Doctors who
worked in ‘the private sector’ were more than 12 times
as likely as those who worked in ‘the public sector’ to
see PCRs at least ‘once a week’(unadjusted OR12.5;
adjusted OR11.837; PB0.001) (Table 2). It was also
noticeable that doctors who worked in both sectors
received more visits than those who worked in the public
sector alone (PB0.001). Doctors who were employed in
both private and public practice were more than three
times as likely as an exclusively public sector employee to
receive at least one visit a week from a PCR (Table 2).
Location of practice setting
There was a significant association between visiting rates
and location of practice setting (P0.002) (Table 1).
Respondents working in Tripoli were more likely to
receive promotional visits than doctors working in Sebha
(PB0.01). Half of the Sebha respondents had been
visited less than twice in the last year compared to
approximately a quarter of the respondents from the two
urban cities (Tripoli and Benghazi). There was no
difference in visiting rates between Tripoli and Benghazi
(P0.07). Doctors in Tripoli (49%), however, were more
likely than doctors in Benghazi (38%) or Sebha (28%) to
meet with PCRs more than once a month. Location of
practice did not influence the likelihood of being visited
at least once a week by PCRs (Table 3).
Area of practice
There were significant differences between visiting rates
according to area of practice (PB0.001) (Table 1).
Residents and anaesthesiologists were less likely to
interact with PCRs on a weekly basis than other groups.
By contrast, the majority of physician specialists (61%)
and other specialists (64%) were visited ‘at least twice
a month’ and ‘once a month’, respectively.
This association also translated to respondents who
reported ‘at least one visit a week’ from a PCR, with
physician specialists (36; 40%), more likely than other
specialists (11; 26%), surgeons (19; 19%), general practi-
tioners (47; 16%), anaesthesiologists (4; 7%) and residents
(1; 2%) to be visited at this high rate.
Logistic regression analysis, using residents as the
predictor variable, revealed that physician specialists
were more than 26 times more likely (unadjusted OR
26.1; 3.4199; P0.002) than a resident to receive pro-
motional visits at least once a week (Table 2). General
practitioners and surgeons were more than eight (GP
unadjusted OR8.2; P0.039), and nine times (surgeon
unadjusted OR9.5; P9.5) as likely as residents to
see PCRs once a week or more (Table 2).
Of the 14 (12 males and 2 females) respondents who
reported that they had been visited at least once a day,
10 were specialists [specialist physician (n6), surgeons
(n2), anaesthesiologists (n1), dermatologist (n1)]
who worked in a hospital setting. The other four doctors
were GPs. By contrast, there were no ‘junior’ resident
medical officers that interacted with PCRs more than
‘once a day’. The highest response for visiting rates
amongst residents was ‘never’ (15; 37%) (Table 2).
Promotional printed material
Promotional printed material was the most frequent gift/
tool (79% of respondents) supplied by PCRs during
promotional visits. The majority of respondents (64%)
received printed material at least twice during the last
year. The frequency of doctors receiving printed materials
differed according to their age groups and years of
practice (PB0.001) (Table 4). Respondents aged 4655
years were more than four times as likely as those aged
2535 to receive printed material (P0.003). Approxi-
mately half (13; 48%) of the junior doctors (13 years of
practice) compared to over three quarters (43; 78%) of
those having ‘ten years of practice or more’ received
printed material at least twice within the last 12 months.
Senior doctors with ‘at least 10 years of practice’ were
more than three times as likely as ‘junior’ doctors to
receive printed materials (PB0.001).
There was a significant association between receiving
printed materials and the respondent’s practice setting
(PB0.001). Fourteen (41%) of the respondents who were
working in the private sector versus 123 (24%) of those
working in the public sector had received printed material
at least five times during the last 12 months (Table 4).
Doctors employed in both public and private sectors
had a similar rate of receiving printed material to those
working in the private sector alone. Doctors who worked
in the private sector alone were more than four times
as likely as those who worked in the public sector
(unadjusted OR4.8; PB0.05) to receive printed mate-
rial. Similarly, doctors who worked in both sectors were
Table 3. Frequency of receiving promotional tools in the
previous 12 months
Number (%)
Never Once 25 times 5 times
Printed materials 128 (21) 94 (15) 223 (37) 163 (27)
Simple gifts 166 (27) 154 (25) 209 (35) 79 (13)
Drug samples 190 (31) 145 (24) 187 (31) 86 (14)
Textbooks 509 (84) 61 (10) 31 (5) 7 (1)
Sponsored items 407 (67) 10 (17) 82 (13) 18 (3)
Direct inducements 511 (84) 46 (8) 36 (6) 15 (2)
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Table 4. Frequency of receiving printed material vs. Doctors’ characteristics
Frequency of receiving printed material vs. Doctors’ characteristics, N (%) Regression analysis (never vs. receiving)
Unadjusted Adjusted
Never Once 25 times 5 times Total Sig OR 95% CI Sig OR 95% CI
Age (Gamma test, PB0.001)
2535 98 (25) 71 (18) 138 (35) 92 (23) 399 1 1
3645V 24 (20) 15 (12) 48 (39) 36 (29) 123 0.248 1.34 0.82.2 0.086 0.415 0.11.1
4655V 4 (6) 5 (8) 30 (47) 25 (39) 64 0.003 4.88 1.713 0.860 1.146 0.25.1
5665V 2 (9) 3 (14) 7 (32) 10 (45) 22 0.116 3.25 0.0714 0.841 0.829 0.15.1
Gender (Mann-Whitney, PB0.05)
Female 59 (25) 38 (16) 83 (35) 57 (24) 237 1 1
Male 69 (19) 56 (15) 140 (38) 106 (29) 371 0.064 1.45 0.92.1 0.970 1.009 0.61.5
Years of practice (Gamma test, PB0.001)
13 83 (29) 54 (19) 86 (30) 65 (23) 288 1 1
46V 13 (16) 14 (17) 35 (43) 20 (24) 82 0.020 2.149 1.14 0.162 1.634 0.83.2
79 10 (22) 5 (11) 19 (42) 11 (24) 45 0.361 1.417 0.672.9 0.378 1.528 0.53.9
]10V 22 (11) 21 (11) 83 (43) 67 (35) 193 B0.001 3.147 1.85.2 0.020 3.932 1.212.4
Practice setting (Kruskal-Wallis, PB0.001)
Public 120 (23) 82 (16) 187 (37) 123 (24) 512 1 1
PrivateV 2 (6) 4 (12) 14 (41) 14 (41) 34 0.031 4.89 1.120 0.104 3.435 0.715.2
BothV 6 (10) 8 (13) 22 (35) 26 (42) 62 0.018 2.85 1.26.7 0.083 2.274 0.85.7
Location of practice setting (Kruskal-Wallis, PB0.01)
Sebha 15 (30) 8 (16) 17 (34) 10 (20) 50 1 1
Benghazi 24 (31) 18 (23.5) 17 (22) 18 (23.5) 77 0.054 1.88 0.93.6 0.11 1.76 0.83.5
TripoliV 89 (19) 68 (14) 189 (39) 135 (28) 481 0.889 .946 0.42.0 0.763 0.87 0.32.03
Area of practice (Kruskal-Wallis, PB0.001)
Residents 21 (51) 10 (24) 8 (20) 2 (5) 41 1 1
AnaesthesiologistsV,# 21 (34) 12 (20) 22 (36) 6 (10) 61 .093 2.00 0.84.4 0.278 1.636 0.63.9
General practitionersV 54 (20) 38 (14) 104 (38) 78 (28) 274 B0.001 4.27 2.168.4 B0.001 3.524 1.77.1
SurgeonsV 13 (13) 23 (23) 39 (39) 24 (24) 99 B0.001 6.94 2.9819 0.004 3.905 1.59.8
OthersV 8 (19) 6 (14) 13 (31) 15 (36) 42 0.003 4.46 1.6611 0.053 2.859 0.98.2
Physician specialistsV,# 11 (12) 5 (5) 37 (41) 38 (42) 91 B0.001 7.63 3.1718 0.066 2.811 0.98.4
Total 128 94 223 163 608
VMann Whitney test significant for comparison with the first category in the same group.





































































































more than twice as likely as those who worked in the
public sector alone to receive printed material (unadjusted
OR2.8; PB0.05) (Table 4). There was a statistically
significant difference in the receipt rate of printed
materials according to the locations of practice setting
(PB0.01). Respondents working in Tripoli were more
likely to receive printed material than those working in
Benghazi or Sebha (PB0.01 and PB0.05, respectively).
The provision of printed material was also influenced
by the doctor’s type of practice or specialty (PB0.001).
Over half of the resident medical officers (n21; 51%)
and one-third of anaesthesiologists (21; 34%) reported
that they had never received any printed materials. By
contrast, physician specialists had the highest rate of
receiving printed material (n80; 88%). Surgeons and
physician specialists were seven times more likely than
their residents to receive printed materials (unadjusted
OR6.94 and 7.63, respectively; PB0.001). Forty-nine
per cent of the residents, compared to 80% (n88) of
physician specialists received printed materials within
the last 12 months. More than two-thirds of general
practitioners, anaesthesiologists, general practitioners,
and surgeons and ‘others’ reported that they received
printed materials within same period. Adjusted logistic
regression showed that area of practice (PB0.01) was the
only statistically significant independent predictor factor
that influenced doctors’ receipt of printed materials
(Table 4).
Simple gifts
Simple gifts were the second most common tools used
by PCRs during their promotional visits. The majority of
respondents (442; 73%) received simple gifts from phar-
maceutical companies. Nearly half of the total respon-
dents (288; 48%) received simple gifts at least twice
during the last year. There was a statistically significant
difference in frequency of receiving simple gifts between
respondents according to their age groups or years of
practice (PB0.001). Approximately one-third (131; 33%)
of the respondents aged 2535 versus only three indivi-
duals (14%) aged 5665 reported they had not received
a gift from a PCR (Table 5) in the last 12 months. By
contrast, doctors with more than 10 years of practice
experience received simple gifts nearly four times as often
as junior doctors (unadjusted OR3.9; PB0.001). Male
doctors (280; 75%) were more likely to receive simple gifts
from pharmaceutical companies than female practi-
tioners (162; 68%; PB0.05) (Table 5).
There was a significant difference in the frequency
of receiving simple gifts according to practice setting
(PB0.001) (Table 4). Participants working solely in
private practice or in both private and public sectors
were more likely to receive simple gifts from PCRs than
those working exclusively in the public sector (PB0.05).
Doctors who worked in ‘both sectors’ were more than six
times as likely as those who worked in the public sector
alone to receive simple gifts (unadjusted OR6.5;
PB0.001; adjusted OR4.3; PB0.01) (Table 5).
A doctor’s area of practice was significantly associated
with the frequency of receiving simple gifts (PB0.001).
Physician specialists were more likely to receive simple
gifts than residents (PB0.001), anaesthesiologists (P
0.001), general practitioners (PB0.001) or surgeons
(P0.018). However, residents were less likely to receive
gifts than anaesthesiologists (unadjusted OR6.5; P
0.001), general practitioners (unadjusted OR5.41;
PB0.001) or surgeons (unadjusted OR6.7; PB0.001).
Out of 79 respondents who had received simple gifts
‘more than five times’, most (n47; 60%) were specialists
[physician specialists, 19; surgeons, 15; anaesthesiologists,
5; dermatologists, 3; paediatricians, 3; urologists, 1; and
gynecologists, 1]. Of the doctors who did not receive
a simple gift in the previous 12 months, the highest
proportion were residents (n28; 68%).
In summary, physician specialists were approximately
14 times as likely to receive simple gifts (PB0.001)
(Table 4). Adjusted logistic regression analysis revealed
that area of practice (P0.001), years of practice
(PB0.05) and practice setting (PB0.01) were the only
independent predictor factors that influenced doctors’
receipt of simple gifts.
Drug samples
The majority of respondents (69%) reported that they
had been given drug samples. Nearly half of the surveyed
respondents (273; 45%) received free samples at least
twice during the last 12 months (Table 6). Generally,
frequency of receiving drug samples was related to age
group or number of years of practice of respondents (PB
0.001). Over two-thirds of respondents older than 45
years (58 out of 86; 67%) received drug samples at least
twice within the last 12 months. Respondents aged 5665
were more than 12 times as likely as doctors aged 2535
to receive drug samples (unadjusted OR12.65; PB
0.05) (Table 6). Senior doctors with ‘at least 10 years
of practice’ were much more likely to be supplied with
drug samples than junior doctors (163; 84% vs. 162; 56%)
(adjusted OR6.41, unadjusted OR3.9, PB0.01).
Male doctors were more likely to receive free samples
than female doctors (PB0.05). Almost half the male
doctors 180 (49%) had been given drug samples at least
twice in the last year compared to female doctors 93
(39%).
There was a significant difference in frequency of
receiving free samples according to a doctor’s practice
setting (PB0.001). Over 90% of doctors working in
private or in both the private and public sectors had
received drug samples compared with 65% of doctors
who worked in the public sector alone (Table 6). Doctors
who worked in the private sector alone or both sectors
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Table 5. Frequency of receiving simple gifts vs. doctors’ characteristics
Frequency of receiving simple gifts vs. doctors’ characteristics, N (%) Regression analysis (never vs. receiving)
Unadjusted Adjusted
Never Once 25 times 5 times Total Sig OR 95% CI Sig OR 95% CI
Labels age (Gamma test, PB0.001)
2535 131 (33) 106 (27) 122 (31) 40 (10) 399 1 1
3645V 25 (20) 26 (21) 50 (41) 22 (18) 123 0.009 1.91 1.13.1 0.126 0.466 0.11.2
4655V 7 (11) 18 (28) 25 (39) 14 (22) 64 0.001 3.98 1.78.9 0.776 0.823 0.23.1
5665V 3 (14) 4 (18) 12 (55) 3 (14) 22 0.073 3.09 0.910.6 0.712 0.737 0.13.7
Gender
Female 75 (32) 62 (26) 74 (31) 26 (11) 237 1 1
Male 91 (25) 92 (25) 135 (36) 53 (14) 371 0.055 1.4 0.992 0.866 0.964 0.61.4
Years of practice (Gamma test, PB0.001)
13 112 (39) 74 (26) 79 (27) 23 (8) 288 1 1
46V 16 (20) 24 (29) 31 (38) 11 (13) 82 B0.01 2.62 1.44.7 0.44 1.916 1.013.6
79V 11 (24) 6 (13) 17 (38) 11 (24) 45 0.066 1.96 0.94.0 0.157 1.895 0.74.5
]10V 27 (14) 50 (26) 82 (42) 34 (18) 193 B0.001 3.91 2.46.2 0.12 4.188 1.312.8
Practice setting (Kruskal-Wallis, PB0.001)
Public 159 (31) 131 (26) 167 (33) 55 (11) 512 1 1
PrivateV 3 (9) 8 (47) 16 (47) 7 (21) 34 0.012 4.65 1.415.4 0.084 2.98 0.810.3
BothV 4 (6) 15 (24) 26 (42) 17 (27) 62 B0.001 6.53 2.318.3 0.009 4.169 1.412.1
Location of practice setting (Kruskal-Wallis, PB0.01)
Sebha 18 (36) 11 (22) 13 (26) 8 (16) 50 1 1
Benghazi 25 (32) 20 (26) 23 (30) 9 (12) 77 0.115 1.63 0.83.0 0.239 1.5 0.72.9
Tripoli 123 (26) 123 (26) 173 (36) 62 (13) 481 0.681 1.17 0.52.4 0.788 0.89 0.32.05
Area of practice (Kruskal-Wallis, PB0.001)
Residents 28 (68) 7 (17) 6 (15) 0 41 1 1
AnaesthesiologistsV 20 (33) 16 (26) 20 (33) 5 (8) 61 B0.001 6.53 2.318.3 0.011 3.261 1.38.1
General practitionersV 78 (28) 78 (28) 87 (32) 31 (11) 274 B0.001 5.41 2.610 B0.001 4.189 2.08.6
SurgeonsV 24 (27) 27 (27) 33 (33) 15 (15) 99 B0.001 6.73 3.0115 0.007 3.326 1.378.0
OthersV,# 4 (17) 7 (17) 22 (52) 9 (21) 42 B0.001 6.53 2.318.3 B0.001 11.65 3.241.8
Physician specialistsV,# 12 (21) 19 (21) 41 (45) 19 (21) 91 B0.001 6.53 2.318.3 0.005 4.79 1.614.1
Total 166 154 209 79 608
VMann-Whitney test significant for comparison with the first category in the same group.







































































































Table 6. Frequency of receiving free drug samples vs. doctors’ characteristics
Frequency of receiving free samples vs. doctors’ characteristics, N ( %) Regression analysis (never vs. receiving)
Unadjusted Adjusted
Never Once 25 times 5 times Total Sig OR 95% CI Sig OR 95% CI
Labels age (Gamma test, PB0.001)
2535 150 (38) 95 (24) 109 (27) 45 (11) 399 1 1
3645V 26 (21) 36 (29) 43 (35) 18 (15) 123 B0.01 2.24 1.393.6 0.41 0.348 0.10.9
4655V 13 (20) 10 (16) 26 (41) 15 (23) 64 0.009 2.36 1.244.4 0.011 0.188 0.050.6
5665V 1 (5) 4 (18) 9 (41) 8 (36) 22 0.014 12.65 1.6895 0.861 1.228 0.112.1
Gender
Female 82 (35) 62 (26) 69 (29) 24 (10) 237 0 1
Male 108 (29) 83 (22) 118 (32) 62 (17) 371 0.155 1.2 0.901.82 0.53 0.876 0.51.3
Years of practice (Gamma test, PB0.001)
13 126 (44) 64 (22) 70 (24) 28 (10) 288 1 1
46V 24 (29) 22 (27) 23 (28) 13 (16) 82 B0.01 2.625 1.103.19 0.219 1.439 0.82.5
79V 10 (22) 13 (29) 17 (38) 5 (11) 45 0.066 1.967 1.25.7 0.024 2.981 1.17.7
]10V 30 (16) 46 (24) 77 (40) 40 (21) 193 B0.001 3.912 2.66.6 0.001 6.398 2.0420
Practice setting (Kruskal-Wallis, PB0.001)
Public 181 (35) 129 (25) 143 (28) 59 (12) 512 1 1
PrivateV 3 (9) 6 (18) 15 (44) 10 (29) 34 0.005 5.65 1.718.7 0.34 3.88 1.113.6
BothV 6 (10) 10 (16) 29 (47) 17 (27) 62 B0.001 5.10 2.112 0.01 3.35 1.38.4
Location of practice setting (Kruskal-Wallis, PB0.01)
Sebha 142 (30) 115 (24) 152 (32) 72 (15) 481 1 1
Benghazi 27 (35) 17 (22) 25 (32) 8 (10) 77 0.071 1.72 0.93.1 0.121 1.69 0.83.2
Tripoli 21 (42) 13 (26) 10 (20) 6 (12) 50 0.432 1.34 0.62.7 0.793 1.117 0.42.5
Area of practice (Kruskal-Wallis, PB0.001)
Residents 30 (73) 6 (15) 3 (7) 2 (5) 41 1 1
Anaesthesiologists# 32 (52) 18 (30) 8 (13) 3 (5) 61 0.038 2.47 1.055.8 0.255 1.713 0.64.3
General practitionersV 89 (32) 72 (26) 84 (31) 29 (11) 274 B0.001 5.66 2.711.8 B0.001 4.489 2.19.5
SurgeonsV,# 20 (20) 25 (25) 36 (36) 18 (18) 99 B0.001 10.77 4.620 B0.001 6.188 2.415.5
OthersV,# 9 (21) 10 (24) 14 (33) 9 (21) 42 B0.001 10.00 3.627.4 0.002 5.620 1.916.5
Physician specialistsV,# 10 (11) 14 (15) 42 (46) 25 (27) 91 B0.001 22.09 8.557.3 B0.001 10.727 3.433.4
Total 190 145 187 86 608
VMann Whitney test significant for comparison with the first category in the same group.

















































































































were more than five times as likely as those who worked
in the public sector alone to receive drug samples
(unadjusted OR5.6 and 5.10; PB0.01) (Table 5).
There was also a significant association between
frequency of receiving free samples and area of practice
(PB0.001). Nearly three quarters of residents (30; 73%)
and just in excess of 50% of anaesthesiologists (32; 52%)
reported that they had never received drug samples
(Table 6). By contrast, more than 80% of specialists (phy-
sician specialists, surgeons, other specialities) received
free samples. Physician specialists were more likely to
receive drug samples than residents, general practitioners,
anaesthesiologists or surgeons (PB0.01 General practi-
tioners were more than five times as likely as residents
to receive simple gifts (unadjusted OR5.66; PB0.001).
Anaesthesiologists were more than twice as likely as
residents to receive free samples (unadjusted OR2.4;
PB0.001).
Adjusted logistic regression modelling for receiving
free samples revealed that doctors’ age group, years of
practice, practice setting and area of practices were the
statistically significant independent predictor factors that
influenced doctors’ receipt of free samples (PB0.05).
Sponsored items
Approximately one-third of respondents (33%) acknowl-
edged that they had received sponsored items (travel,
luggage, assistance with conference attendance or pro-
vision of meals) at least once during the last year.
Frequency of receiving sponsored items differed between
respondents according to their age groups and years of
practice (PB0.001). Seventy per cent of doctors older
than 45 years received at least one sponsored item
compared with 43% of respondents younger than 45
years (Table 7). Male respondents were more likely to
receive sponsored items than females (PB0.05).
The frequency of receiving sponsored items was also
influenced by their area of practice (PB0.001). There
were significant differences between physician specialists
and residents, general practitioners and surgeons (PB
0.001). The majority of physician specialists (51; 56%)
had received at least one sponsored item. There was
a lower rate amongst general practitioners (80; 30%),
surgeons (30; 29%), anaesthesiologists (22; 36%) and
residents (3; 7%). Physician specialists were more than
16 times as likely as residents to receive sponsored items
(unadjusted OR16.15; adjusted OR5.6; PB0.001)
(Table 7).
Textbooks
Ninety-nine respondents (16%) received one or more
textbooks in the last year (Table 3). Of the 99 respondents
who admitted to receiving a textbook, 61 (62%) received
one book, 31 received two to five books and 7 doctors
received more than five textbooks in the last 12 months.
Direct inducements
Ninety-seven doctors (16%) admitted to receiving direct
inducements from PCRs (Table 3). Approximately one-
half (46 out of 97) of these respondents received one
inducement and 15% (15 of the 97) received inducements
more than five times during the last year. There was
a significant difference in likelihood of receiving direct
inducements according to their practice setting with
(PB0.01). Doctors working in both sectors ‘private and
public’ were more likely to receive inducements than
those who worked in the public sector alone (PB0.001).
Almost one-third (20; 32%) of doctors who worked in
both sectors received inducements compared to approxi-
mately one-sixth of those who worked solely in public
practice (71; 14%).
Discussion
A total of 608 out of the 1000 Libyan doctors surveyed
responded to the questionnaire, which exceeded our
targeted return of 50%. The majority of doctors (574;
96%) indicated that they had been visited by PCRs in the
previous 12 months, and approximately half were visited
at least once a month. By comparison, Libyan doctors
were visited less frequently than their Turkish and
Tunisian counterparts (72% of doctors were visited at
least once a month) (29, 32) and considerably less than
the four times a month rate commonly reported in
Western developed countries (USA/Canada/NZ) (11,
3437). In Libya, pharmaceutical marketing activities
have increased in the last decade but appear less prevalent
than in other countries.
This study found almost all medical practitioners
(91%) reported that they had received gifts during the
previous year. Many kinds of marketing tools were used
but printed materials (79%), simple gifts (73%) and drug
samples (69%) were the most common promotional gifts
supplied. This is concordant with Australian (38),
Japanese (39), German (40) and US (41) results, which
reported that simple gifts and drug samples were the most
common tools used by PCRs. Reimbursements or
sponsored items were received by 33% of respondents.
PCRs commonly used printed materials to increase
awareness and knowledge about their products and to
influence attitudes and behaviour. Printed materials are
essential components of all marketing strategies and
provide written reinforcement of any verbal message
provided by PCRs during their promotional visits. They
are relatively inexpensive compared with others tools and
are an enduring product that allow medical practitioners
to review then re-examine the content at a convenient
time.
The common use of printed material in Libya was
similar to distribution in another developing country
(Nigeria) where postable printed material was the most
common promotional item distributed by PCRs (42).
Mustafa A. Alssageer and Stefan R. Kowalski
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Table 7. Frequency of receiving sponsored items vs. doctors’ characteristics
Frequency of doctors’ receiving sponsored items, N (%) Logistic Regression (never vs. receiving)
Unadjusted Adjusted
Never Once 25 times ]5 times Total Sig OR 95% CI Sig OR 95% CI
Age, PB0.001 (Gamma test)
2535 297 (74) 47 (12) 46 (12) 9 (2) 399 1 1
3645V 74 (60) 25 (20) 18 (15) 6 (5) 123 0.248 1.34 0.82.2 0.166 0.545 0.21.2
4655V 26 (41) 21 (33) 15 (23) 2 (3) 64 0.003 4.88 1.713 0.980 0.987 0.32.7
5665V 10 (45) 8 (36) 3 (14) 1 (5) 22 0.116 3.25 0.714 0.678 0.768 0.22.6
Years of practice, PB0.001 (Gamma test)
13 225 (78) 28 (10) 30 (10) 5 (2) 288 1 1
46 56 (68) 15 (18) 8 (10) 3 (4) 82 0.068 1.658 0.92.8 0.201 1.446 0.82.5
79 31 (69) 7 (16) 6 (13) 1 (2) 45 0.175 1.613 0.83.2 0.186 1.680 0.73.6
]10V 95 (49) 51 (26) 38 (20) 9 (5) 193 B0.001 3.684 2.45.4 0.003 4.211 1.610.8
Area of practice, PB0.001 (Kruskal-Wallis)
Residents 38 (93) 1 (2) 2 (5) 0 (0) 41 1
AnaesthesiologistsV 39 (64) 10 (16) 10 (16) 2 (3) 61 0.003 7.145 1.925.8 0.014 5.328 1.420.1
General practitionersV 194 (71) 44 (16) 30 (11) 6 (2) 274 0.007 5.223 1.517.4 0.023 4.117 1.213.9
SurgeonsV 69 (70) 17 (17) 10 (10) 3 (3) 99 0.008 5.507 1.519.2 0.115 2.87 0.710.6
OthersV 27 (64) 7 (17) 7 (17) 1 (2) 42 0.004 7.037 1.826.7 0.28 4.73 1.119.0
Physician specialistsV,# 40 (44) 22 (24) 23 (25) 6 (7) 91 B0.001 16.15 4.656.1 0.012 5.66 1.422.04
Total 407 101 82 18 608
VMann-Whitney test significant for comparison with the first category in the same group.

















































































































In developing countries, PCRs are frequently the only
source of drug information (43), and they provide
information to doctors about their company’s products
in a variety of ways, including verbal presentations and
written materials. In Pakistan, 75% of physicians sur-
veyed admitted that they used information from leaflets
when prescribing (44). In Libya, journal advertising,
direct mail and e-detailing activities are not widely
used; therefore, it is not unexpected that provision of
written material during visits was common.
The content of printed material is subject to regulation
in many countries. The Libyan Health Law Act number
106 of 1973 and its explanatory notes of 1975 prohibit
any advertising of pharmaceutical preparation by words
or phrases, which may be unethical. Deciding between
ethical and unethical advertising is difficult, but written
information supplied by PCRs in developing countries
can be biased. In a study conducted in Pakistan, Rohra
et al. (45) audited 340 pamphlet and brochure advertise-
ments from pharmaceutical companies and observed that
18% of advertisements were adjudged to be misleading
and exaggerated, 32% were ambiguous, 21% were false
and 21% were adjudged as controversial (45). Similarly, in
a Bangladesh study, 34% of the brochures claims were
found to be misleading and were categorised as provid-
ing; controversial claims (50%), exaggerated claims (22%)
or ambiguous statements 16% (46). In India, Roy et al.
interviewed 25 doctors and 36 PCRs. The PCRs admitted
that the verbal information conveyed about the promoted
products was often inconsistent with the written materi-
als. Doctors also indicated that the PCRs provided
literature backup only when repeatedly requested (47).
In this study, we did not review and assess the quality of
the written information provided by the PCRs, but it
should be stressed, however, that although content may
be biased and the quality of information supplied
variable, the availability and ready access to this form
of drug information is often more convenient than ob-
taining information from other sources. In the absence of
independent sources of information in Libya, the use of
commercial information therefore is a more convenient
resource than retrieval of independent evidence based
information (48, 49).
The majority of respondents (442; 73%) in our study
received simple gifts from pharmaceutical companies.
Receiving trivial value gifts from PCRs can introduce
an unconscious and unintentional self-serve bias since
simple stationery gifts with the names of products exposes
physicians to specific company products. Katz et al.
indicated that stationery gifts that display the brand name
of a specific product can have a subtle influence on
a doctor’s prescribing decisions (50) and this silent
information regarding brand products, is often more
influential than verbal reminders (51). The decision-
making process can be influenced by retrieval of brand
information from memory, and this knowledge can be
acquired from sources in the external environment (52).
Accordingly, the more exposed a doctor is to a promoted
product; the more likely it is to enter prescribing
consideration. These promotional products even influ-
ence medical students’ attitudes toward product brands
(53). Therefore, all prescribers should acknowledge
that even simple gifts are part of a complex combined
marketing strategy to influence behaviour. In addition, an
individual’s impulse to reciprocate for even trivial gifts is
often underestimated (17).
Providing prescription drug samples is one of the
major marketing activities undertaken by pharmaceutical
companies (54) and a common reason for PCR visits. In
the United States and England, 92 and 78% doctors
reported receiving drug samples from PCRs, respectively
(38, 41). The result of the current study (69% of
respondents received drug samples) is similar but not as
high as the level of sample provision in other countries.
Since a drug sample will ultimately be used by a
patient, as compared to other pharmaceutical promo-
tional tools (personal gifts), the acceptance of samples
may be regarded as more ethically acceptable (55).
Doctors who dispense free samples may believe they are
helping patients, rather than believing that PCRs are
attempting to influence their prescribing behaviour (11,
56). A Turkish study reported that 44% of doctors
believed free drug samples were extremely useful and
84% of respondents used drug samples often or always
(57). Morgan et al. found that the main reasons doctors
provide drug samples were financial (93.5%), ready
availability of the samples (89.1%) or patient request
(76.1%) (55). Patient request is more prevalent in devel-
oped countries where marketing directly or indirectly to
consumers can introduce a further complexity to the
provision and supply of drug samples. Companies pro-
mote their drug to potential prescribers (‘‘push strategy’’)
and also encourage patients to request prescription of
their product (‘‘pull strategy’’). Direct patient requests
have therefore also been reported to influence doctors’
prescribing decisions (5759).
The potential to provide ‘free’ pharmaceuticals to
patients may encourage physicians to accept PCR visits
(23). Any benefit, however, must be balanced by the
realization that sample provision is a specific marketing
and promotional tool designed to influence drug pre-
scription (54). Several studies have shown that the
availability of drug samples may increase subsequent
prescription of sampled drugs and compromise patient
outcomes. Warrier et al. reviewed 40 studies and found
that availability of drug samples influenced doctors’
prescribing decisions, increased promoted brand pro-
ducts, decreased prescribing of generic and inexpensive
medications and decreased adherence to prescribing
practice guidelines. Furthermore, they reported that less
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than half of practitioners believed that the presence
of drug samples could affect their prescribing behaviour
and most practitioners stated that accepting drug samples
was not unethical (60). Therefore, it should be remem-
bered that although free medication samples may seem
to reduce the financial cost initially, they may result
in continuing prescription that is more expensive. The
provision of free samples is therefore extremely benefi-
cial to pharmaceutical companies. It increases both the
exposure of the representative to the prescribing decision-
maker and also increases brand awareness.
The variables for this study included, the age of the
participants and years of medical practice, which logically
should correspond. Out of 608 of participant doctors,
385(63%) of the respondents were in the younger age
group (2535) and subsequently were junior doctors (13
years of medical practice). Out of the 385 junior doctors,
only (n35; 9%) said they were visited ‘at least once
a week’ (Table 2). By contrast, of the 84 (14%) doctors
older than age 45 who also had ]10 years of practice
experience, 29 (34.5%) met with PCRs at least once
a week. Our study found area of practice was a signifi-
cant factor even when adjusted for all other variables.
Physician specialists interacted commonly with PCRs
and the majority of physician specialists (73%) saw PCRs
‘at least once a month’ compared to 44% of general
practitioners and 17% of residents. Physician specialists
were also 26 times more likely than resident medical
officers to see a representative more than once a week.
Specialists were, therefore, highly targeted by PCR pro-
motional activities. Although simple cheap gifts (station-
ery and printed materials) were commonly distributed
to all doctors, sponsored items and drug samples were
more likely to be provided to specialists. The majority of
physician specialists (56%) admitted receipt of a spon-
sored item compared to only 7.3% of residents and 29.2%
of general practitioners. In Australia, 52% of medical
specialists reported that had received offers of travel to
conferences (61).
With the exception of anaesthesiologists, specialists
also received more drug samples than non-specialists.
Eighty-nine per cent of physician specialists received free
samples compared to 68% of general practitioners. PCRs
therefore invest considerable effort toward specialist
clients. The association between visiting rate and area
of practice has been reported in other studies (62).
Identifying, targeting and influencing opinion leaders
remains a critical component of promotional activities
(63). According to diffusion theory, behavioural change in
medical practitioners can be commenced and then dif-
fused among others if enough opinion leaders (specialists)
within the medical health services are acknowledged
and able to adopt, endorse and support the behaviour
(64). Pharmaceutical companies therefore invest consider-
able resources in maintaining and encouraging positive
relationships with specialists. Opinion leaders are con-
sidered to be reliable sources of information and impose
influence on consumer decisions (65). Opinion leaders
(specialists) can produce multiplier marketing influences
(66) and ‘reduce’ the indecision of other practitioners
regarding their prescription choices. Medical practitioners
who are sceptical about pharmaceutical industry informa-
tion may be influenced indirectly by specialist ‘opinion
leaders’ (67, 68). In many developing countries, lack of
access to independent sources of drug information can
lead to doctors seeking information and advice from
their specialist colleagues. Kisa’s study in Turkey found
that 75% of doctors completely agreed that doctors
who worked in hospitals had their prescribing decisions
affected by the department head and their colleague’s
opinions (69, 70). Prescribing of a new drug by peers helps
inform physicians about a treatment’s effects and has a
significant impact on attitude toward the new medicine.
Medical specialists therefore have a higher threshold of
influence than other prescribers and assist in ‘legitimizing’
prescribing of new drugs.
Thus the return on investment of detailing to opinion
leaders may be much higher than is suggested by just the
opinion leader’s prescription volume (66).
The 15 largest pharmaceutical companies spend 32%
of their total advertising expenses on opinion leaders (66,
69). Steinman et al. observed that during the1990s, 35 of
the 40 opinion-leader doctors who were been targeted by
Parke-Davis were involved in at least one promotional
activity (71). Pharmaceutical companies employ higher
standard detailers to carry out detailing activities to
opinion leaders (66). The targeting of physician specia-
lists by PCRs is therefore a key marketing tool to induce
or influence attitudes to prescribing and exceeds the mere
transfer of product information.
Another reason for increased focus on specialists
concerns their role as prescription initialisers. A Dutch
study reported that two-thirds of family practitioners’
prescriptions for cardiovascular drugs were for regimens
initiated by specialists (72).
By contrast, in Australia, some family doctors have
higher PCR visiting rates than specialists (38). Since
studies have also demonstrated a relationship between
high-prescription rates and the number of interactions
between doctors and PCRs (73), it can be assumed that
high prescription volume general practitioners are also
considered critical promotional clients. Doctors who are
known as heavy prescribers are therefore more likely to
become the targets of PCRs (74, 75). Vancelik et al. found
that the rate of PCR visits to general practitioners, who
had a burden of more than 60 patients a day, was at a
higher rate than the rate of those doctors who examined
less than 60 patients a day (29). The influence of heavy
prescribers for particular pharmaceutical products leads
to an increase in the popularity and loyalty amongst
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other medical practitioners. PCRs exploiting social
validations have used an individual’s peer group to en-
courage prescribing of their products (76).
The lowest number of PCR interactions was recorded
with resident medical officers. This result concurs with
other studies performed in developing countries. Previous
studies examining the interactions between residents and
PCRs in Tatarstan (31) and Libya found that residents in
both countries had low visiting rates compared with other
practitioners. A large proportion of residents (between 37
and 47% of respondents) indicated that they had never
communicated with PCRs. In both studies, no ‘junior’
resident medical officer interacted with PCRs every day.
Forty-four per cent of residents in Tatarstan interacted
with PCRs once or twice each week compared with only
2% who interacted ‘once a week’ in Libya. By contrast,
studies in the United States and the United Kingdom
revealed that residents were visited anywhere between two
to four and five times a month by PCRs, respectively (73).
Doctors who were practicing in the private sector,
whether in private practice alone or dual practice, had the
opportunity to frequently interact with PCRs. Two-thirds
of doctors who worked in the private sector met with
PCRs at least once a week and were also more likely to
receive printed materials, simple gifts and free samples
compared with practitioners who worked only in public
practice.
Private sector targeting by PCRs therefore seems more
aggressive than with the public sector. Private practice
has only recently become a more prevalent component
of the Libyan healthcare environment. There is a percep-
tion amongst some Libyans that private medical care
is associated with improved health care (77). Since the
salaries of civil servants and employees of state-owned
services have been largely frozen since 1981 (78), more
medical practitioners may have also chosen to supple-
ment income by working in the private practice alone or
in dual practice (19, 77). In this study, the number of
specialists who were private practitioners or who main-
tained dual practice (private and public) was 68 and
71%, respectively; hence, the increased visits may also be
explained in part by the large proportion of specialists
working in the private sector.
Male doctors displayed a higher rate of interaction
with PCRs compared to their female counterparts. Male
doctors displayed a higher rate of receiving simple gifts,
drug samples and sponsored items from PCRs compared
to their female counterparts This result is inconsistent
with Anderson et al.’s study in the United States which
found no significant differences in PCRs’ interactions
with the doctors surveyed according to their gender (28).
This variation could be due to different communication-
culture relationships in Libya.
Most of the health facilities and senior specialist
medical staff are located in major cities; therefore,
respondents working in Tripoli were more likely to see
PCRs and receive printed materials than doctors working
in Sebha.
Sixteen per cent of respondents admitted that they had
received direct inducements for prescribing promoted
drugs. Offering commissions for prescribing a particular
drug from a particular company is illegal in most
countries. But from an industry perspective, competitive
marketing practices are designed to increase sales not to
provide unbiased information and professional back up
to doctors (79). If there is an absence of legislation or
suitable codes of conducts for interactions between PCRs
and doctors, PCRs may be tempted to use less ethical
marketing practices in return for prescribing a specific
drug especially if dictated by strict sales targets (47).
Interactions between representatives and doctors can
produce a conflict of interest and may encourage less
ethical practice, and doctors should always remember
that they are being targeted by companies to increase
sales of selected products. What’s best for the patient
should always dictate the prescription decision. Since the
acceptance of small gifts can progress to larger or more
expensive gifts, some researchers (80) are of the belief that
all gifts whether large or small are not appropriate and
should be prohibited (50).
Involvement in pharmaceutical promotion may lead
to less rational prescribing choices (11, 8185), and a
positive correlation has been reported between the cost of
physicians’ prescribing and the frequency of PCR visits
(27). In developing countries, such as Libya, there is no
mechanism to monitor pharmaceutical company activ-
ities. Although advertising of any pharmaceutical pre-
paration by words or phrases that cannot be proven is
prohibited, enforcement of this regulation is difficult and
there are no other guidelines that dictate pharmaceutical
promotional activities. Therefore, governmental and in-
stitutional intervention is needed to minimize unethical
promotional practices. Legislation, guidelines or agreed
codes of conduct would assist both medical practitioners
and representatives to conform to an agreed standard of
promotional activities. The WHO has established ethical
criteria which constitute the general principals of promo-
tion that can be adapted by governments (86). At the time
of the survey, we were not aware of any formal written
guidelines at any of the institutions involved in the survey.
In addition, education regarding the ethics, psychology
and promotional techniques used by pharmaceutical
companies should be included in the curriculum of
medical and pharmacy schools in Libya.
The current study had several limitations. It was a
descriptive, self-reporting study that employed a focused,
as opposed to a random sampling method. There was a
potential for both recall and response bias. We employed
a ‘convenience sample’ with the majority of targeted insti-
tutions being teaching hospitals; therefore, generalisation
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beyond this sampling framework is not possible. Further
studies employing more extensive and inclusive criteria
are required.
Conclusions
Libyan doctors were frequently visited by PCRs and the
provision of commercial information, reminder gifts, free
samples and sponsored items were the major inducements
tools used by PCRs.
Specialists and medical practitioners in the private
sector had the highest rate of interactions with PCRs.
Government and national medical agencies should also
take practical positions in monitoring pharmaceutical
promotion activities to ensure consistent standards. Our
study highlighted that there is a need, in Libya, to pro-
duce National Guidelines for health professionals’ inter-
actions with pharmaceutical companies. This should
involve sufficient consultation between medical educators,
health organisations and the pharmaceutical industry.
Key messages
. Pharmaceutical company representatives (PCRs)
commonly interact with Doctors in Libya.
. Accepting gifts from PCRs can generate potential
conflicts of interest between the PCR and a medical
practitioner.
. Specialists as opinion leaders are especially targeted
for promotional activities.
. The establishment of an approved code of conduct
for pharmaceutical promotional activities needs to be
established in Libya.
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Health service providers used in the study.
Tripoli:
. University Hospitals:
 Central Tripoli Hospital
 Tripoli Medical Centre
. Public hospitals:
 Tajora Central Heart and Cardiac Medical Center
 Al Jala Women Hospital
 The Diabetes Hospital
 Metiga Military Hospital














 Al Marwa Hospital
Sebha:
. University Hospitals:
 Sebha Medical Centre
. Private Hospitals:
 Al Manar
 Belkys Maternity Hospital
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